CD151 Overexpression: Prognosis and Therapy in EGFR-Negative NSCLC
This study explores CD151’s (a protein linked to cancer progression) role in non-small cell lung cancer (NSCLC) patients without EGFR mutations, who have limited treatment options. Analysing 157 adenocarcinoma biopsies […]